PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.
about
Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance.Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.PharmGKB summary: Efavirenz pathway, pharmacokineticsPharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health TransitionAn Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS PatientsPharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions.Pharmacogenomic implications of the evolutionary history of infectious diseases in AfricaCytochrome P450 pharmacogenetics in African populations: implications for public health.Nuclear receptors and drug metabolism for the personalization of cancer therapy.The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics.Pharmacogenetics of nevirapine excretion into breast milk and infants' exposure through breast milk versus postexposure prophylaxis.Precision medicine for HIV: where are we?Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.
P2860
Q33708471-9EEF37DB-5D6A-43A5-9445-00939151F4D1Q33909996-D5774BE0-C481-4EAA-A39F-8A0045C13C1BQ35706069-EE997A05-5077-40F7-AAC0-B972FD6E47A2Q35846143-EF9422C3-6643-4F18-99B0-760B829DBC43Q36105822-7C5CAE76-23C1-444A-9E52-CE71A3F3C710Q36437792-91E57162-650D-41E9-AF13-509206BA9894Q36554279-2BCCE98A-0585-4C21-98DD-FAB779FAF21BQ37130938-7A6F7211-F504-4EC3-8B8B-0A2DF2177DBAQ37737731-80148E07-3884-4231-8833-23C427371A42Q38192688-6535D9A4-9A98-4BA0-8790-4316B66924F3Q38704025-CCA6EF38-74C8-49BB-AAC3-22282CEC74C6Q38851258-30EA2068-1A3F-4FE6-ABC5-EE65D85E31E6Q38957969-FCF9CA4C-E715-4D28-83EB-FD71F8423EF9Q46158508-234487E5-F121-472E-B57B-D065CD0DA423Q46828123-7E004C92-F590-4AA7-AEEB-50B5BCDF2344Q47569821-51E558C1-D29C-4090-94DE-6DA6DF205997Q47906608-8A3D87F0-4A5F-4216-AB9D-AC3677166FE6Q49332317-1C711573-7866-4055-94AC-7B311B472DA0Q50042411-6824792C-F751-42FD-A342-29860E7E8823
P2860
PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PXR and CAR single nucleotide ...... uth African HIV/AIDS patients.
@ast
PXR and CAR single nucleotide ...... uth African HIV/AIDS patients.
@en
type
label
PXR and CAR single nucleotide ...... uth African HIV/AIDS patients.
@ast
PXR and CAR single nucleotide ...... uth African HIV/AIDS patients.
@en
prefLabel
PXR and CAR single nucleotide ...... uth African HIV/AIDS patients.
@ast
PXR and CAR single nucleotide ...... uth African HIV/AIDS patients.
@en
P2093
P2860
P921
P356
P1433
P1476
PXR and CAR single nucleotide ...... uth African HIV/AIDS patients.
@en
P2093
Heather Whitehorn
Marelize Swart
Peter Smith
P2860
P2888
P356
10.1186/1471-2350-13-112
P577
2012-11-22T00:00:00Z